• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[化疗不良反应对浸润型肺结核患者生活质量指标的影响]

[Influence of adverse reactions due to chemotherapy on life quality indices in patients with infiltrative pulmonary tuberculosis].

作者信息

Mordyk A V, Antropova V V

出版信息

Probl Tuberk Bolezn Legk. 2008(9):44-6.

PMID:19065734
Abstract

The study included 72 patients with infiltrative pulmonary tuberculosis who were divided into two groups: a study group (n = 39) showing adverse reactions to antituberculous drugs and a control one (n = 33). Examination of life quality parameters by MOS SF-36 scale revealed a reduction in the parameters characterizing the physical and psychosocial status of the patients, which was more pronounced in those with adverse reactions to chemotherapy within the first 2 months of treatment. The revealed changes make it necessary to implement additional therapeutic and psychotherapeutic measures in the first months of treatment for tuberculosis.

摘要

该研究纳入了72例浸润性肺结核患者,这些患者被分为两组:研究组(n = 39),对抗结核药物有不良反应;对照组(n = 33)。采用MOS SF-36量表对生活质量参数进行检查发现,表征患者身体和心理社会状况的参数有所降低,在治疗的前2个月内对化疗有不良反应的患者中这种情况更为明显。所揭示的这些变化使得有必要在结核病治疗的最初几个月内实施额外的治疗和心理治疗措施。

相似文献

1
[Influence of adverse reactions due to chemotherapy on life quality indices in patients with infiltrative pulmonary tuberculosis].[化疗不良反应对浸润型肺结核患者生活质量指标的影响]
Probl Tuberk Bolezn Legk. 2008(9):44-6.
2
[Changes in the patients' mental status in the tolerability of antituberculous drugs].[抗结核药物耐受性中患者精神状态的变化]
Probl Tuberk Bolezn Legk. 2009(3):38-42.
3
[Frequency and pattern of adverse reactions due to treatment of patients with pulmonary tuberculosis with antitubercular reserve drugs].
Probl Tuberk Bolezn Legk. 2004(10):6-10.
4
[Some specific features of life quality in patients with pulmonary tuberculosis].[肺结核患者生活质量的一些特定特征]
Probl Tuberk Bolezn Legk. 2003(4):29-30.
5
[The use of fenazid in patients with pulmonary tuberculosis with poor isoniazid tolerance].[对异烟肼耐受性差的肺结核患者使用非那齐德的情况]
Probl Tuberk Bolezn Legk. 2003(7):34-7.
6
[Comparative characterization of life quality in patients with pulmonary tuberculosis after surgical treatment].
Probl Tuberk Bolezn Legk. 2004(7):7-10.
7
[Intensive chemotherapy tolerance in old patients with pulmonary tuberculosis].[老年肺结核患者的强化化疗耐受性]
Probl Tuberk Bolezn Legk. 2004(9):25-8.
8
[Study on the efficacy and safety of short-term treatment including fluoroquinolones anti-tuberculosis drugs for rifampicin resistant pulmonary tuberculosis].[含氟喹诺酮类抗结核药物的短期治疗方案用于耐利福平肺结核的疗效与安全性研究]
Zhonghua Liu Xing Bing Xue Za Zhi. 2009 Feb;30(2):179-83.
9
[Incidence and pattern of recurrent side effects in persons with different haptoglobin phenotypes during chemotherapy of pulmonary tuberculosis].[不同触珠蛋白表型的肺结核患者化疗期间复发副作用的发生率及模式]
Probl Tuberk. 1998(4):23-4.
10
[Effect of ascorbic acid and emoxypin on the efficiency of complex chemotherapy for infiltrative pulmonary tuberculosis].
Ter Arkh. 2009;81(11):21-4.